CD40 and autoimmune disease: A humanized anti-CD154 antibody (hu5C8) was developed with the objective of suppressing CD40-mediated immune activation in autoimmune disease and transplantation but clinical trails were complicated by increased thromboembolic events and had to be halted [56].